Accéder au contenu
Merck

Craviten hydrolysis in plasma in vitro.

Polish journal of pharmacology and pharmacy (1981-10-01)
E Pogonowska-Wala
RÉSUMÉ

Craviten hydrolysis in vitro was studied in human, rat and canine plasma and erythrocytes. Craviten was degraded during the incubation with plasma and the hydrolysis was inhibited by trimethoxybenzoic acid, a metabolite of Craviten. Erythrocyte enzymes do not participate in the hydrolysis.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
3,4,5-Trimethoxybenzoic acid, ReagentPlus®, 99%